Advertisement

Author: Ned Douthat

Gilead Sciences: Groundbreaking Value

Gilead Sciences (GILD) has been a serial disappointer among the biotechnology sector, as pipeline concerns have dragged the stock down by 31% over the last twelve months compared to a 13.6% gain in the S&P 500.  Gilead...

Read More

Charles Schwab Surges on Quarterly Report

San Francisco retail brokerage and fund manager Charles Schwab (SCHW) was one of just a few gainers on the NYSE on Friday, soaring more than 6% as broad market indexes slumped more than 2%.  The reason for the rise...

Read More

How Did JP Morgan Really Do?

JP Morgan (JPM) was the first of the major banks to report second quarter earnings and the headline figures were quite positive.  Quarterly profits rose 76% to $4.8 billion or $1.09 per share, and analysts’ expected...

Read More

GM Peddling Cars to Investment Bankers

A good business man never lets an opportunity go to waste, at least that’s what GM’s CEO Ed Whitacre believes.  As General Motors prepares to emerge from bankruptcy with what will likely be the second largest...

Read More

SIGN UP TO NEWSLETTER

Join our mailing list to receive the latest news and updates from our team.